Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues

Journal of General Virology

Volumn 95, Issue PART 9, 2014, Pages 2038-2049

  de Motes, Carlos Maluquer ^a,b,c   Schiffner, Torben ^b,d   Sumner, Rebecca P ^a,b   Smith, Geoffrey L ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODIMER; LYSINE; MONOMER; N1 PROTEIN; PROTEIN BCL 2; UBIQUITIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRUS PROTEIN;

ALLELE; ARTICLE; BINDING SITE; CONTROLLED STUDY; COVALENT BOND; DIMERIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; UBIQUITINATION; VACCINIA; VACCINIA VIRUS; VIRUS VIRULENCE;

ANIMALS; APOPTOSIS; CELL LINE; CERCOPITHECUS AETHIOPS; DIMERIZATION; HEK293 CELLS; HUMANS; LYSINE; MACROPHAGES; MICE; MUTATION; NF-KAPPA B; UBIQUITINATION; VACCINIA; VACCINIA VIRUS; VIRAL PROTEINS; VIRULENCE FACTORS;

EID: 84906279127     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.065664-0     Document Type: Article

References (57)

1. Aoyagi, M., Zhai, D., Jin, C., Aleshin, A. E., Stec, B., Reed, J. C. & Liddington, R. C. (2007). Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci 16, 118-124.
2. Barrios-Rodiles, M., Brown, K. R., Ozdamar, B., Bose, R., Liu, Z., Donovan, R. S., Shinjo, F., Liu, Y., Dembowy, J. & other authors (2005). High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307, 1621-1625.
3. Barry, M., van Buuren, N., Burles, K., Mottet, K., Wang, Q. & Teale, A. (2010). Poxvirus exploitation of the ubiquitin-proteasome system. Viruses 2, 2356-2380.
4. Bartlett, N., Symons, J. A., Tscharke, D. C. & Smith, G. L. (2002). The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol 83, 1965-1976.
5. Beaudenon, S. & Huibregtse, J. M. (2008). HPV E6, E6AP and cervical cancer. BMC Biochem 9 (Suppl 1), S4.
6. Bhoj, V. G. & Chen, Z. J. (2009). Ubiquitylation in innate and adaptive immunity. Nature 458, 430-437.
7. Chen, R. A., Jacobs, N. & Smith, G. L. (2006). Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J Gen Virol 87, 1451-1458.
8. Chen, R. A., Ryzhakov, G., Cooray, S., Randow, F. & Smith, G. L. (2008). Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog 4, e22.
9. Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J. & Green, D. R. (2010). The BCL-2 family reunion. Mol Cell 37, 299-310.
10. Cooray, S., Bahar, M. W., Abrescia, N. G., McVey, C. E., Bartlett, N. W., Chen, R. A., Stuart, D. I., Grimes, J. M. & Smith, G. L. (2007). Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol 88, 1656-1666.
11. Demirov, D. G., Ono, A., Orenstein, J. M. & Freed, E. O. (2002). Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci U S A 99, 955-960.
12. DiPerna, G., Stack, J., Bowie, A. G., Boyd, A., Kotwal, G., Zhang, Z., Arvikar, S., Latz, E., Fitzgerald, K. A. & Marshall, W. L. (2004). Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by Toll-like receptors. J Biol Chem 279, 36570-36578.
13. Ember, S. W., Ren, H., Ferguson, B. J. & Smith, G. L. (2012). Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. J Gen Virol 93, 2098-2108.
14. Fedosyuk, S., Grishkovskaya, I., de Almeida Ribeiro, E., Jr & Skern, T. (2014). Characterization and structure of the vaccinia virus NF-κB antagonist A46. J Biol Chem 289, 3749-3762.
15. Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Côté, M. & other authors (2001). Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65.
16. Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H. & other authors (2011). Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596.
17. Gloeckner, C. J., Boldt, K., Schumacher, A., Roepman, R. & Ueffing, M. (2007). A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes. Proteomics 7, 4228-4234.
18. González, J. M. & Esteban, M. (2010). A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history. Virol J 7, 59.
19. González-Santamaría, J., Campagna, M., García, M. A., Marcos-Villar, L., González, D., Gallego, P., Lopitz-Otsoa, F., Guerra, S., Rodríguez, M. S. & other authors (2011). Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins. J Virol 85, 12890-12900.
20. Graham, S. C., Bahar, M. W., Cooray, S., Chen, R. A., Whalen, D. M., Abrescia, N. G., Alderton, D., Owens, R. J., Stuart, D. I. & other authors (2008). Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog 4, e1000128.
21. Guerin, J. L., Gelfi, J., Boullier, S., Delverdier, M., Bellanger, F. A., Bertagnoli, S., Drexler, I., Sutter, G. & Messud-Petit, F. (2002). Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins. J Virol 76, 2912-2923.
22. Gustin, J. K., Moses, A. V., Früh, K. & Douglas, J. L. (2011). Viral takeover of the host ubiquitin system. Front Microbiol 2, 161.
23. Kalverda, A. P., Thompson, G. S., Vogel, A., Schröder, M., Bowie, A. G., Khan, A. R. & Homans, S. W. (2009). Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. J Mol Biol 385, 843-853.
24. Kamio, M., Yoshida, T., Ogata, H., Douchi, T., Nagata, Y., Inoue, M., Hasegawa, M., Yonemitsu, Y. & Yoshimura, A. (2004). SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein. Oncogene 23, 3107-3115.
25. Komander, D. (2009). The emerging complexity of protein ubiquitination. Biochem Soc Trans 37, 937-953.
26. Komander, D. & Rape, M. (2012). The ubiquitin code. Annu Rev Biochem 81, 203-229.
27. Kvansakul, M., van Delft, M. F., Lee, E. F., Gulbis, J. M., Fairlie, W. D., Huang, D. C. & Colman, P. M. (2007). A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak. Mol Cell 25, 933-942.
28. Liao, T. L., Wu, C. Y., Su, W. C., Jeng, K. S. & Lai, M. M. (2010). Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J 29, 3879-3890.
29. Maluquer de Motes, C., Cooray, S., Ren, H., Almeida, G. M. F., McGourty, K., Bahar, M. W., Stuart, D. I., Grimes, J. M., Graham, S. C. & Smith, G. L. (2011). Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence. PLoS Pathog 7, e1002430.
30. Mammas, I. N., Sourvinos, G., Giannoudis, A. & Spandidos, D. A. (2008). Human papilloma virus (HPV) and host cellular interactions. Pathol Oncol Res 14, 345-354.
31. Mansur, D. S., Maluquer de Motes, C., Unterholzner, L., Sumner, R. P., Ferguson, B. J., Ren, H., Strnadova, P., Bowie, A. G. & Smith, G. L. (2013). Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog 9, e1003183.
32. Martin-Serrano, J. (2007). The role of ubiquitin in retroviral egress. Traffic 8, 1297-1303.
33. Mercer, J., Snijder, B., Sacher, R., Burkard, C., Bleck, C. K., Stahlberg, H., Pelkmans, L. & Helenius, A. (2012). RNAi screening reveals proteasome-and Cullin3-dependent stages in vaccinia virus infection. Cell Rep 2, 1036-1047.
34. Mo, M., Fleming, S. B. & Mercer, A. A. (2009). Cell cycle deregulation by a poxvirus partial mimic of anaphase-promoting complex subunit 11. Proc Natl Acad Sci U S A 106, 19527-19532.
35. Mohamed, M. R., Rahman, M. M., Lanchbury, J. S., Shattuck, D., Neff, C., Dufford, M., van Buuren, N., Fagan, K., Barry, M. & other authors (2009). Proteomic screening of variola virus reveals a unique NFkappaB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc Natl Acad Sci U S A 106, 9045-9050.
36. Moss, B. (2007). Poxviridae: the viruses and their replicaton. In Fields Virology, 5th edn, pp. 2905-2946. Edited by D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman & S. E. Straus. Philadelphia, PA: Lippincott Williams & Wilkins.
37. Nerenberg, B. T., Taylor, J., Bartee, E., Gouveia, K., Barry, M. & Früh, K. (2005). The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factories. J Virol 79, 597-601.
38. Parkinson, J. E. & Smith, G. L. (1994). Vaccinia virus gene A36R encodes a Mr 43-50 K protein on the surface of extracellular enveloped virus. Virology 204, 376-390.
39. Peters, N. E., Ferguson, B. J., Mazzon, M., Fahy, A. S., Krysztofinska, E., Arribas-Bosacoma, R., Pearl, L. H., Ren, H. & Smith, G. L. (2013). A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog 9, e1003649.
40. Pickart, C. M. (2001). Mechanisms underlying ubiquitination. Annu Rev Biochem 70, 503-533.
41. Postigo, A. & Way, M. (2012). The vaccinia virus-encoded Bcl-2 homologues do not act as direct Bax inhibitors. J Virol 86, 203-213.
42. Randow, F. & Lehner, P. J. (2009). Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11, 527-534.
43. Satheshkumar, P. S., Anton, L. C., Sanz, P. & Moss, B. (2009). Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes. J Virol 83, 2469-2479.
44. Shchelkunov, S. N. (2010). Interaction of orthopoxviruses with the cellular ubiquitin-ligase system. Virus Genes 41, 309-318.
45. Smith, G. L., Benfield, C. T., Maluquer de Motes, C., Mazzon, M., Ember, S. W., Ferguson, B. J. & Sumner, R. P. (2013). Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 94, 2367-2392.
46. Sonnberg, S., Seet, B. T., Pawson, T., Fleming, S. B. & Mercer, A. A. (2008). Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes. Proc Natl Acad Sci U S A 105, 10955-10960.
47. Sperling, K. M., Schwantes, A., Schnierle, B. S. & Sutter, G. (2008). The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex. Virology 374, 234-239.
48. Taylor, R. T., Lubick, K. J., Robertson, S. J., Broughton, J. P., Bloom, M. E., Bresnahan, W. A. & Best, S. M. (2011). TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe 10, 185-196.
49. Teale, A., Campbell, S., Van Buuren, N., Magee, W. C., Watmough, K., Couturier, B., Shipclark, R. & Barry, M. (2009). Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication. J Virol 83, 2099-2108.
50. Thurston, T. L., Ryzhakov, G., Bloor, S., von Muhlinen, N. & Randow, F. (2009). The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 10, 1215-1221.
51. Unterholzner, L., Sumner, R. P., Baran, M., Ren, H., Mansur, D. S., Bourke, N. M., Randow, F., Smith, G. L. & Bowie, A. G. (2011). Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog 7, e1002247.
52. van Buuren, N., Couturier, B., Xiong, Y. & Barry, M. (2008). Ectromelia virus encodes a novel family of F-box proteins that interact with the SCF complex. J Virol 82, 9917-9927.
53. Welchman, R. L., Gordon, C. & Mayer, R. J. (2005). Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 6, 599-609.
54. Wilton, B. A., Campbell, S., Van Buuren, N., Garneau, R., Furukawa, M., Xiong, Y. & Barry, M. (2008). Ectromelia virus BTB/kelch proteins, EVM150 and EVM167, interact with cullin-3-based ubiquitin ligases. Virology 374, 82-99.
55. Yamazaki, K., Gohda, J., Kanayama, A., Miyamoto, Y., Sakurai, H., Yamamoto, M., Akira, S., Hayashi, H., Su, B. & Inoue, J. (2009). Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling. Sci Signal 2, ra66.
56. Yasuda, J., Nakao, M., Kawaoka, Y. & Shida, H. (2003). Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol 77, 9987-9992.
57. Zhang, L., Villa, N. Y. & McFadden, G. (2009). Interplay between poxviruses and the cellular ubiquitin/ubiquitin-like pathways. FEBS Lett 583, 607-614.